跳至主要内容
临床试验/NCT06044038
NCT06044038招募中不适用

Enhancing Functional Capacity and Body Composition of Individuals With Schizophrenia Through a Physical Exercise Intervention

Università degli Studi di Ferrara2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
2
主要终点
Screen for Cognitive Impairment in Psychiatry (SCIP)

研究概览

简要总结

The study aims to investigate the feasibility and adherence of long-term, moderate-intensity different types of physical activity programs for individuals with schizophrenia. Secondary outcomes are related to the control of non-communicable disease risk factors and the improvement of exercise capacity, body composition and cognitive function.

详细描述

Schizophrenia is a common public health issue that generates a social and economic burden. Individuals affected by schizophrenia experience severe and chronic levels of disability that derive from acute psychotic symptoms, as well as cognitive impairments for which available treatments offer only limited benefits. Moreover, their life expectancy is lower, and they have a higher prevalence of heart diseases risk factors such as obesity, dyslipidemia, smoking, hypertension, diabetes and physical inactivity than the general population. The World Health Organization and the European Mental Health Action Plan 2013-2020 acknowledge the role of physical activity in mental health and encourage the inclusion of lifestyle changes in education and treatment programs for people with mental illness, delivered in primary and secondary healthcare settings. The benefits of regular physical activity are well-recognized and are inversely associated with mortality risk and the incidence of many chronic diseases. Moreover, it plays a critical role in preserving and even improving cognitive function throughout the lifespan. However, people with schizophrenia tend to be less engaged in physical activity programs than the general population and report a range of barriers such as pain, side effects of medications and negative symptoms.

The purpose of this trial is to evaluate the efficacy of an exercise-based intervention program among people with schizophrenia.

All individuals with schizophrenia were screened for eligibility. After verifying inclusion and exclusion criteria and after eligibility is confirmed, written informed consent must be obtained prior to randomization. Baseline patient characteristics (i.e., demographics, medical history, laboratory test results) have been collected and recorded for further assessment. Randomization was performed during the inclusion visit (T1). Randomization will be performed centrally using an internet-based system. The identification number (ID) and the treatment allocation will be assigned by the randomization system. Patients were randomized to physical activity group or usual care by a 2:1 allocation. After the randomization, all participants underwent the same battery of tests and questionnaires according to the study protocol.

All patients were involved in the usual care cognitive program. It was held in weekly 90-minute sessions in a Psychiatric Rehabilitation Center of the Healthcare District of Ferrara. Specialized psychiatric therapists conduct this program with groups of 5-10 participants, based on a Cognitive Remediation model. Each session consists of welcoming participants, reviewing tasks conducted in the last meeting, and assignment of new pen-and-pencil cognitive and metacognitive tasks. Tasks include games and exercises (e.g., sudoku, crosswords), as well as discussions aimed at improving short- and long-term memory (i.e., repeating sequences of words and numbers), executive functions, and social cognition, with progressive adaptation of task difficulty. The total number of sessions is 50 for a duration of 12 months. In addition, the intervention arm was involved in a supervised exercise-based program. They could voluntarily participate in a variety of activities such as walking or Nordic walking groups, gentle gymnastics, soccer, swimming, and volleyball. Each activity was scheduled twice a week.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with schizophrenia for at least 1 year
  • On antipsychotic medications with the same therapeutic regimen for at least 3 months before enrolment
  • Free of symptomatic peripheral arterial occlusive disease and cardiovascular, pulmonary, neurological, metabolic, and orthopaedic disorders that could interfere with physical activity sessions

排除标准

  • Recent modification of the therapeutic regimen
  • Presence of symptomatic peripheral arterial occlusive disease and cardiovascular, pulmonary, neurological, metabolic, and orthopaedic disorders that could interfere with physical activity sessions

结局指标

主要结局

Screen for Cognitive Impairment in Psychiatry (SCIP)

时间窗: First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

Values range from 0 to \>100, higher scores mean a better outcome

Peak Oxygen Uptake (VO2peak)

时间窗: First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

Measurement of cardiorespiratory fitness, reported as ml/kg/min and estimated through a moderate and perceptually regulated 1km treadmill walk test (1k-TWT) or through related short-forms (500m or 200m)

Body Mass Index (kg/m²)

时间窗: First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

Derived from the measurement of weight in kilograms and height in meters

Waist circumference (cm)

时间窗: First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

Measurement of waist circumference

Frontal Assessment Battery (FAB)

时间窗: First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

Values range from 0 to18, higher scores mean a better outcome

次要结局

  • Adherence(From date of enrollment until the date of the end of follow-up (up to 2 years))

研究者

发起方
Università degli Studi di Ferrara
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mandini Simona

Professor

Università degli Studi di Ferrara

研究点 (2)

Loading locations...

相似试验